Abstracts

GEOGRAPHICAL DIFFERENCES IN FUNCTIONAL IMPAIRMENT OF PEOPLE WITH HIV

Functional impairments occur at a younger age among people with HIV (PWH). However, studies to date have not compared differences in functional impairment across diverse regions in a global HIV cohort. We sought to explore multinational differences by Global Burden of Disease (GBD) regions in functional status and associated factors in the REPRIEVE cohort. REPRIEVE…

GUT MICROBIOTA, PLASMA METABOLOMICS, AND ATHEROSCLEROSIS IN HIV INFECTION

Alterations in gut microbiota and blood metabolomic profiles have been implicated in HIV infection and cardiovascular disease respectively. However, it remains unclear whether alterations in gut microbiota and related functional components may contribute to disrupted host blood metabolomic profiles in relation to atherosclerosis, especially in the context of HIV infection. We analyzed cross-sectional associations between…

MACROPHAGE ARTERIAL INFILTRATION RELATES TO PLAQUE TYPE AND IMMUNE ACTIVATION IN HIV

Persistent immune activation and downstream macrophage-specific arterial infiltration are thought to contribute to heightened atherosclerotic cardiovascular disease (ASCVD) risk among people with HIV (PWH) on ART. We applied a novel macrophage-specific imaging modality to investigate macrophage-specific infiltration among participants with vs without HIV in relation to atherosclerotic plaque and immune activation. Twenty PWH on ART…

TRENDS IN MYOCARDIAL INFARCTION RISK BY HIV STATUS IN 2 US HEALTHCARE SYSTEMS

With the potential adverse cardiovascular effects of newer antiretroviral therapy (ART), such as integrase inhibitors and weight gain and Tenofovir Alafenamide and elevated lipids, it is critical to continue monitoring trends in myocardial infarction (MI) rates by HIV status. Subjects included people with HIV (PWH) from two health system cohorts: Massachusetts General Hospital (Partners) and…